Vaxxas, a clinical-stage biotechnology company, has announced the appointments of three globally respected vaccine experts as ...
(NASDAQ:UPXI) (the 'Company' or 'Upexi'), a brand owner specializing in the development, manufacturing and distribution of consumer products and is actively pursuing additional investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback